BLTE Earnings

BLTE reported its FY2025Q4 earnings on 2026-03-02, showcasing a revenue of against an estimate of 50.00M, resulting in a 0% surprise. The EPS was -0.38, surpassing the expected -0.56 by 32.14%. The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following BLTE's FY2025Q4 earnings announcement on 2026-03-02, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, BLTE's stock price tends to shift by an average of -6.87% in the 10 days leading up to earnings and 4.71% in the 10 days following, providing insight into potential market.

For , analysts estimate BLTE's annual revenue to reach undefined, while the EPS is projected at -0.51. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between BLTE's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, BLTE's stock price typically moves by -6.87% in the 10 days before its earnings and 4.71% in the 10 days after. For the upcoming earnings, analysts expect an EPS of -0.51 and revenue of undefined.

The earnings call summary reveals several negative indicators: significant net loss increase, operational delays in trial enrollment, and high R&D and G&A expenses. Despite a strong cash position, financial strain is evident due to increased share-based compensation. Additionally, management's unclear responses on SG&A expenses and operational timelines raise concerns. The market cap suggests moderate volatility, leading to a predicted stock price movement in the negative range of -2% to -8% over the next two weeks.